HighTower Advisors’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,745
Closed -$53K 3966
2024
Q3
$53K Buy
8,745
+500
+6% +$3.31K ﹤0.01% 3407
2024
Q2
$58K Buy
+8,245
New +$58K ﹤0.01% 3283
2024
Q1
Sell
-13,867
Closed -$122K 3859
2023
Q4
$122K Buy
+13,867
New +$102K ﹤0.01% 3153
2021
Q2
Sell
-33,200
Closed -$342K 3292
2021
Q1
$342K Sell
33,200
-6,500
-16% -$62.8K ﹤0.01% 2206
2020
Q4
$360K Buy
+39,700
New +$286K ﹤0.01% 1819
2016
Q1
Sell
-12,225
Closed -$115K 2149
2015
Q4
$115K Buy
+12,225
New +$106K ﹤0.01% 1833
2015
Q2
Sell
-7,375
Closed -$329K 1665
2015
Q1
$329K Sell
7,375
-84,335
-92% -$789K ﹤0.01% 1206
2014
Q4
$1.06M Buy
91,710
+14,210
+18% +$140K 0.02% 771
2014
Q3
$553K Sell
77,500
-1,550
-2% -$10.8K 0.01% 990
2014
Q2
$560K Sell
79,050
-912
-1% -$5.34K 0.01% 1017
2014
Q1
$490K Sell
79,962
-2,248
-3% -$16.5K 0.01% 989
2013
Q4
$719K Buy
+82,210
New +$503K 0.01% 820

Other funds holding MDXG

HighTower Advisors's MDXG Position: Q4 2024 in Review

HighTower Advisors sold out of MiMedx Group (MDXG) in Q4 2024, closing a stake of 8,745 shares — an estimated $53K sold.

HighTower Advisors first reported a position in MDXG in Q4 2013 and held it in 12 quarters. The position peaked at $1.06M in Q4 2014. 213 funds tracked by Wall St. Rank hold MDXG as of Q4 2024.

  • HighTower Advisors reported no remaining MiMedx Group position as of Q4 2024 after selling out during the quarter.
  • HighTower Advisors sold 8,745 MiMedx Group shares in Q4 2024, an estimated $53K.
  • HighTower Advisors first reported a position in MiMedx Group in Q4 2013 and held it in 12 quarters.
  • HighTower Advisors's MiMedx Group position peaked at $1.06M in Q4 2014.
  • 213 funds tracked by Wall St. Rank held MiMedx Group as of Q4 2024.

Based on HighTower Advisors's 13F filing for Q4 2024, filed 7 Feb 2025.